Pfizer’s Covid-19 drug a potential game changer
In the overall study population through Day 28, no deaths were reported in patients who received Paxlovid as compared to 10 deaths in patients who received placebo
In the overall study population through Day 28, no deaths were reported in patients who received Paxlovid as compared to 10 deaths in patients who received placebo
Applications remain under review by others including U.S. Food and Drug Administration and the European Medicines Agency
The process is completed with the help of a balloon at a low temperature so that other cells are undamaged and the patient can return home the next day
Sun Pharma has reported consolidated financial results for the period ended September 30, 2021.
Expertise in exosomes isolation and characterization will drive innovation in this field
Dr. Reddy's Laboratories has reported consolidated financial results for the period ended September 30, 2021
It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years
The acquisition expands Takeda’s immuno-oncology and innate immune cell therapy portfolio with novel platforms leveraging T cells for the potential treatment of solid tumours and haematological malignancies
Its unique technology, ChetoSensar gives new promise to ADCs by alleviating solubility challenges
The collaboration provides KardiaMobile users quick access to doctors worldwide for consultations about their ECG readings
Subscribe To Our Newsletter & Stay Updated